Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change
PLOS One · 2026
DOI: 10.1371/journal.pone.0346614 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Nur Hasnah Maamor und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, UCSI University, UCSI Hospital, Port Dickson, Negeri Sembilan, Malaysia. Hauptthemen laut MEDLINE: Hypertension, Renin-Angiotensin System, Climate Change, Adaptation, Physiological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education Malaysia.
Abstract (Originalsprache)
Hypertension (HT) is a ‘by-product’ to the forces of natural selection against environmental drift and salt availability, therefore contributed to differential HT susceptibility. This study provides further supporting evidence through: (i) associating three salt-sensitive related candidate gene variants, to the susceptibility of HT among the Malays from Peninsular Malaysia with a detail genotype-phenotype evaluation; (ii) comparing the blood pressure and the frequency spectrums of these variants across global populations; (iii) correlating them with the geographical coordinates and BP of the respective populations, and evaluating the presence of local adaptation in these candidate variants. We tested the genetic association of six SNPs underlying CYP11B2 , AGT and ADRB2 in 918 normotensives and hypertensives Malays, men and women. CYP11B2 and ADRB2 were associated with elevated BP in males and females, respectively. Evaluation of these gene variations across 38 populations residing in different latitudinal clines revealed strong correlations between CYP11B2 , AGT and latitudinal coordinates; whilst ADRB2 to a weaker extent. Tajima’s D analyses suggested a non-neutral evolution on CYP11B2 , which suggested a modest putative signals of local adaptation. In summary, we complement the notion that effective pharmacogenetic marker(s) to predict responsiveness of anti-HT medication requires comprehensive characterization of population genetics and HT phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, UCSI University, UCSI Hospital, Port Dickson, Negeri Sembilan, Malaysia.
- Evidence Based Healthcare Sector, National Institute of Health (NIH), Shah Alam, Selangor, Malaysia.
- Faculty of Applied Science, UCSI University, Wilayah Persekutuan, Kuala Lumpur, Malaysia.
- Key Laboratory of Computational Biology, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
- Cardiology Unit, Prince Court Medical Centre, Jalan Kia Peng, Kuala Lumpur, Malaysia.
- UiTM Private Specialist Centre, Jalan Hospital, Sungai Buloh, Selangor, Malaysia.
ORCID-Profile: Hoh Boon-Peng
Förderung
- Ministry of Higher Education Malaysia
Zitieren
APA
Maamor, N. H., Cengnata, A., Pan, Y., Rizal Ismail, J., Abd Malek, K., Williams, G. H., Yusoff, K., & Boon-Peng, H. (2026). Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change. PLOS One. https://doi.org/10.1371/journal.pone.0346614
Vancouver
Maamor NH, Cengnata A, Pan Y, Rizal Ismail J, Abd Malek K, Williams GH, et al. Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change. PLOS One. 2026. doi:10.1371/journal.pone.0346614
BibTeX
@article{Maamor2026,
author = {Maamor, Nur Hasnah and Cengnata, Alvin and Pan, Yuwen and Rizal Ismail, Johan and Abd Malek, Khasnur and Williams, Gordon H and Yusoff, Khalid and Boon-Peng, Hoh},
title = {Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0346614}
}
EUVIMED